← Back to Search

Patient Group / Arm for Neurological Disorders

N/A

Waitlist Available

Research Sponsored by Synaptrix Labs Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Severe quadriparesis

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial is testing a new technology called Neuralis that helps people with severe muscle and nerve problems control their wheelchair using their brain signals. The study wants to see if Neuralis is safe, practical,

Who is the study for?

This trial is for individuals with severe paralysis due to conditions like Multiple Sclerosis, Spinal Cord Injury, or ALS. Participants must be able to attend all tests, give consent, speak English fluently, and have a study partner. It's not suitable for those who can't use the device properly.Check my eligibility

What is being tested?

The EMPOWER study is testing Neuralis, a non-invasive brain-computer interface (BCI) that allows people with paralysis to control their wheelchairs using EEG signals from their visual cortex by focusing their attention.See study design

What are the potential side effects?

Since this technology is non-invasive and involves wearing an EEG headset for wheelchair control, side effects may include discomfort at the sensor sites on the scalp or fatigue from concentration required to operate the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have severe weakness in all four limbs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Device safety and efficacy

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patient Group / ArmExperimental Treatment1 Intervention

Use of non-invasive EEG headband device

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Synaptrix Labs Inc.Lead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"According to the updated information on clinicaltrials.gov, this specific study is not currently accepting participants. The trial was initially posted on November 1st, 2024 and last edited on January 16th, 2024. However, it's noteworthy that there are currently a total of 1622 other ongoing trials seeking eligible candidates at present."

Answered by AI

Is it possible for me to participate in this research trial?

"This clinical study aims to enroll 6 individuals, aged between 21 and 75 years old, who are experiencing paralysis. It is important that potential participants satisfy the following requirements: be willing and able to attend all clinical assessments regardless of their geographical location, have severe quadriparesis, possess the capacity to provide informed consent, meet the criteria as a suitable candidate for the device being tested in this trial, demonstrate proficiency in English language skills, and have a designated study partner."

Answered by AI